These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Decreasing the use of restraint and seclusion among psychiatric inpatients. Hellerstein DJ; Staub AB; Lequesne E J Psychiatr Pract; 2007 Sep; 13(5):308-17. PubMed ID: 17890979 [TBL] [Abstract][Full Text] [Related]
5. The use of clozapine in a mentally retarded and aggressive population. Cohen SA; Underwood MT J Clin Psychiatry; 1994 Oct; 55(10):440-4. PubMed ID: 7961521 [TBL] [Abstract][Full Text] [Related]
6. Clinical response to clozapine treatment of 11 chronic patients in a state psychiatric hospital. Herman M Aust N Z J Ment Health Nurs; 1997 Sep; 6(3):129-33. PubMed ID: 9384012 [TBL] [Abstract][Full Text] [Related]
7. Predictors of violent behavior among acute psychiatric patients: clinical study. Amore M; Menchetti M; Tonti C; Scarlatti F; Lundgren E; Esposito W; Berardi D Psychiatry Clin Neurosci; 2008 Jun; 62(3):247-55. PubMed ID: 18588583 [TBL] [Abstract][Full Text] [Related]
8. Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder. Chengappa KN; Ebeling T; Kang JS; Levine J; Parepally H J Clin Psychiatry; 1999 Jul; 60(7):477-84. PubMed ID: 10453803 [TBL] [Abstract][Full Text] [Related]
9. The effects of clozapine on aggression and substance abuse in schizophrenic patients. Volavka J J Clin Psychiatry; 1999; 60 Suppl 12():43-6. PubMed ID: 10372611 [TBL] [Abstract][Full Text] [Related]
10. Preventive aggression devices (PADS): ambulatory restraints as an alternative to seclusion. Van Rybroek GJ; Kuhlman TL; Maier GJ; Kaye MS J Clin Psychiatry; 1987 Oct; 48(10):401-5. PubMed ID: 3667538 [TBL] [Abstract][Full Text] [Related]
11. Rating aggression in the clinical setting. A retrospective adaptation of the Overt Aggression Scale: preliminary results. Sorgi P; Ratey J; Knoedler DW; Markert RJ; Reichman M J Neuropsychiatry Clin Neurosci; 1991; 3(2):S52-6. PubMed ID: 1687961 [No Abstract] [Full Text] [Related]
12. Seclusion and restraint in patients with schizophrenia: clinical and biographical correlates. Steinert T; Bergbauer G; Schmid P; Gebhardt RP J Nerv Ment Dis; 2007 Jun; 195(6):492-6. PubMed ID: 17568297 [TBL] [Abstract][Full Text] [Related]
13. Clozapine: its impact on aggressive behavior among patients in a state psychiatric hospital. Chengappa KN; Vasile J; Levine J; Ulrich R; Baker R; Gopalani A; Schooler N Schizophr Res; 2002 Jan; 53(1-2):1-6. PubMed ID: 11728832 [TBL] [Abstract][Full Text] [Related]
14. A review of agitation in mental illness: treatment guidelines and current therapies. Marder SR J Clin Psychiatry; 2006; 67 Suppl 10():13-21. PubMed ID: 16965191 [TBL] [Abstract][Full Text] [Related]
15. Violence and schizophrenia: clozapine as a specific antiaggressive agent. Buckley P; Bartell J; Donenwirth K; Lee S; Torigoe F; Schulz SC Bull Am Acad Psychiatry Law; 1995; 23(4):607-11. PubMed ID: 8639988 [TBL] [Abstract][Full Text] [Related]
16. Nadolol in the treatment of aggression in chronic psychiatric inpatients. Wong MK; Lee S J Clin Psychiatry; 1993 Jun; 54(6):235. PubMed ID: 8331093 [No Abstract] [Full Text] [Related]
17. Risperidone use at a state hospital: a clinical audit 2 years after the first wave of risperidone prescriptions. Chengappa KN; Sheth S; Brar JS; Parepally H; Marcus S; Gopalani A; Palmer A; Baker RW; Schooler NR J Clin Psychiatry; 1999 Jun; 60(6):373-8. PubMed ID: 10401915 [TBL] [Abstract][Full Text] [Related]